ERBB2 and neoplasm: A class of ESP, the designed ankyrin repeat proteins (DARPins), demonstrated excellent results for radionuclide molecular imaging of HER2 in preclinical studies, providing high tumor-to-nontumor tissue ratio shortly after injection [22,23,24].